Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients

Abstract Background General control non-derepressible protein 1 (GCN1), a ribosome-binding protein, has been implicated in the development and progression of multiple cancers. However, the potential role of GCN1 in hepatocellular carcinoma (HCC) has not yet been investigated. Methods The expression...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhongchao Zhang, Caijun Rao, Mingcun Hu, Wei Yan, Zhipeng Du
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-025-03732-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850094869475753984
author Zhongchao Zhang
Caijun Rao
Mingcun Hu
Wei Yan
Zhipeng Du
author_facet Zhongchao Zhang
Caijun Rao
Mingcun Hu
Wei Yan
Zhipeng Du
author_sort Zhongchao Zhang
collection DOAJ
description Abstract Background General control non-derepressible protein 1 (GCN1), a ribosome-binding protein, has been implicated in the development and progression of multiple cancers. However, the potential role of GCN1 in hepatocellular carcinoma (HCC) has not yet been investigated. Methods The expression of GCN1 in HCC was analyzed using multiple databases. Bioinformatics analysis was employed to investigate the correlation of GCN1 expression with clinical significance and immune infiltration in HCC. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, gene set enrichment analysis (GSEA), and in vitro experiments were conducted to study the function and potential mechanisms of GCN1 in HCC. Results GCN1 was significantly upregulated in HCC, which was associated with worse clinicopathological features and poorer prognosis of the patients. GCN1 expression was closely associated with immune cell infiltration in HCC. GSEA analysis showed that GCN1 was involved in several tumor-related signaling pathways, including cell cycle, DNA replication, and Wnt signaling pathway. Knockdown of GCN1 inhibited the proliferation, invasion and migration of HCC cells, and also down-regulated the expression levels of cell cycle protein cyclin B1 (CCNB1), cyclin D1 (CCND1), and Wnt signaling pathway-related proteins Wnt3A and β-catenin. Conclusion GCN1 overexpression was associated with HCC progression and poor prognosis, and GCN1 knockdown could suppress the proliferation, migration and invasion ability of HCC cells by regulating Wnt signaling pathway, suggesting the potential of GCN1 as a prognostic and therapeutic target for HCC.
format Article
id doaj-art-e0695a9529904fa0a7dd2e9b0c9e1797
institution DOAJ
issn 1475-2867
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj-art-e0695a9529904fa0a7dd2e9b0c9e17972025-08-20T02:41:33ZengBMCCancer Cell International1475-28672025-03-0125111710.1186/s12935-025-03732-yHighly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patientsZhongchao Zhang0Caijun Rao1Mingcun Hu2Wei Yan3Zhipeng Du4Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background General control non-derepressible protein 1 (GCN1), a ribosome-binding protein, has been implicated in the development and progression of multiple cancers. However, the potential role of GCN1 in hepatocellular carcinoma (HCC) has not yet been investigated. Methods The expression of GCN1 in HCC was analyzed using multiple databases. Bioinformatics analysis was employed to investigate the correlation of GCN1 expression with clinical significance and immune infiltration in HCC. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, gene set enrichment analysis (GSEA), and in vitro experiments were conducted to study the function and potential mechanisms of GCN1 in HCC. Results GCN1 was significantly upregulated in HCC, which was associated with worse clinicopathological features and poorer prognosis of the patients. GCN1 expression was closely associated with immune cell infiltration in HCC. GSEA analysis showed that GCN1 was involved in several tumor-related signaling pathways, including cell cycle, DNA replication, and Wnt signaling pathway. Knockdown of GCN1 inhibited the proliferation, invasion and migration of HCC cells, and also down-regulated the expression levels of cell cycle protein cyclin B1 (CCNB1), cyclin D1 (CCND1), and Wnt signaling pathway-related proteins Wnt3A and β-catenin. Conclusion GCN1 overexpression was associated with HCC progression and poor prognosis, and GCN1 knockdown could suppress the proliferation, migration and invasion ability of HCC cells by regulating Wnt signaling pathway, suggesting the potential of GCN1 as a prognostic and therapeutic target for HCC.https://doi.org/10.1186/s12935-025-03732-yGCN1Hepatocellular carcinomaImmune infiltrationPrognosisWnt signaling pathway
spellingShingle Zhongchao Zhang
Caijun Rao
Mingcun Hu
Wei Yan
Zhipeng Du
Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
Cancer Cell International
GCN1
Hepatocellular carcinoma
Immune infiltration
Prognosis
Wnt signaling pathway
title Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
title_full Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
title_fullStr Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
title_full_unstemmed Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
title_short Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
title_sort highly expressed gcn1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients
topic GCN1
Hepatocellular carcinoma
Immune infiltration
Prognosis
Wnt signaling pathway
url https://doi.org/10.1186/s12935-025-03732-y
work_keys_str_mv AT zhongchaozhang highlyexpressedgcn1isassociatedwithcancerprogressionandpoorprognosisinhepatocellularcarcinomapatients
AT caijunrao highlyexpressedgcn1isassociatedwithcancerprogressionandpoorprognosisinhepatocellularcarcinomapatients
AT mingcunhu highlyexpressedgcn1isassociatedwithcancerprogressionandpoorprognosisinhepatocellularcarcinomapatients
AT weiyan highlyexpressedgcn1isassociatedwithcancerprogressionandpoorprognosisinhepatocellularcarcinomapatients
AT zhipengdu highlyexpressedgcn1isassociatedwithcancerprogressionandpoorprognosisinhepatocellularcarcinomapatients